International Online Tool for Therapeutic Decision Making in NSCLC (V2.0)

This poster, developed in collaboration with David R. Gandara, MD, and other noted experts in lung cancer, was presented in September 2015 at the 16th World Conference on Lung Cancer in Denver, Colorado. The poster highlights an innovative online tool developed to help facilitate therapeutic decision making in NSCLC. A considerable increase in TKI use was documented by comparing tool usage data we collected in 2014 vs data collected via a similar tool in 2012. More users were likely to select TKIs in both EGFR mutation (49% in 2012 vs 67% in 2014) and ALK translocation (35% vs 61%) with a corresponding decrease in use of chemotherapy. Of note, clinicians reported that their use of the tool would influence their choice of treatment in 86% of cases, demonstrating that online tools can make a substantial difference in clinical decision making.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?